相关实验视频

Updated: Jun 5, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

索马托斯塔丁受体2基因表达和免疫景观在鼻恶性瘤的表征

Elisabetta Xue¹, Dara Bracken-Clarke¹, Harris Krause²

¹Center for Immuno-Oncology, National Cancer Institute, National Institute of Health, Bethesda, MD 20894, USA.

|December 17, 2024

概括

嗅觉神经母细胞瘤 (ONB),鼻腔未分化癌 (SNUC) 和鼻腔神经内分泌癌 (SNEC) 是罕见的鼻腔癌. SSTR2的表达有所不同,ONB显示出新疗法的潜力,而SNUC可能对免疫瘤学治疗有反应.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
免疫学免疫学免疫学

背景情况:

嗅觉神经母细胞瘤 (ONB),鼻腔未分化癌 (SNUC) 和鼻腔神经内分泌癌 (SNEC) 是罕见的鼻腔恶性瘤,治疗选择有限.
索马托斯坦素受体2基因 (SSTR2) 表达在神经内分泌瘤中具有治疗作用,并且在这些瘤中已报告.

研究的目的:

分析SSTR2基因表达及其与基因组特征的关联,免疫反应生物标志物以及ONB,SNUC和SNEC中的瘤免疫微环境.
为了确定这些罕见的鼻恶性瘤的潜在治疗策略.

主要方法:

在47个鼻腔瘤样本 (26个ONB,13个SNUC,8个SNEC) 中分析SSTR2基因表达.
评估T细胞炎症 (TCI) 评分和免疫细胞透使用解卷.
对基因组特征的评估,包括与SSTR2表达相关的增殖途径.

主要成果:

在神经类型的ONB中,SSTR2的表达高,在基底类型的ONB,SNUC和SNEC中低.
与ONB (3.9%) 和SNEC (0%) 相比,SNUC显示T细胞炎症瘤的比例更高 (38.5%),比ONB (3.9%) 和SNEC (0%) 高.
在ONB中高SSTR2表达与增加的自然杀手细胞,树突细胞和增殖途径相关.

结论:

在ONB,SNUC和SNEC之间存在SSTR2表达和免疫特征的显著差异.
具有高SSTR2表达的ONB为新的治疗组合提供了机会.
SNUC的炎症微环境表明免疫瘤疗法的潜在有效性.

关键词:

在RNA-Seqq.外基因组测序是指外基因组的测序.嗅觉神经母细胞瘤鼻腔神经内分泌癌癌瘤鼻腔未分化的癌瘤索马托斯坦因子受体2 这些是瘤生物标志物.瘤微环境是一个微环境.

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...